Wells Fargo raised the firm’s price target on AptarGroup to $132 from $121 and keeps an Overweight rating on the shares. The firm remains constructive as demand fundamentals accelerate in Pharma, B+H maintains a recovery path, and cost savings materialize. Additionally, Wells envisions long-term value creation from internal investments and capital return.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ATR: